Clinical Trial Update: Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding [Phase 4]

View source ↗

Summary

Phase 4 trial comparing terlipressin, somatostatin, and octreotide for control of variceal bleeding in cirrhosis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Variceal Bleeding

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)
• Somatostatin (somatostatin)
• Terlipressin (terlipressin)

Snippet

Sponsor: Korea University | Conditions: Variceal Bleeding, Cirrhosis | Phase 4 | Status: COMPLETED | Results posted: 2018-03-19